SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010719
Filing Date
2015-11-13
Accepted
2015-11-13 16:31:04
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20150930.htm 10-Q 1291016
2 EX-31.1 kura-ex311_7.htm EX-31.1 15591
3 EX-31.2 kura-ex312_6.htm EX-31.2 15412
4 EX-32.1 kura-ex321_8.htm EX-32.1 8659
  Complete submission text file 0001564590-15-010719.txt   4404295

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kura-20150930.xml EX-101.INS 703917
6 XBRL TAXONOMY EXTENSION SCHEMA kura-20150930.xsd EX-101.SCH 43926
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20150930_cal.xml EX-101.CAL 38135
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20150930_def.xml EX-101.DEF 135891
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20150930_lab.xml EX-101.LAB 302931
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20150930_pre.xml EX-101.PRE 245065
Mailing Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037
Business Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 151229531
SIC: 2834 Pharmaceutical Preparations